Skip to Main content Skip to Navigation
New interface
Journal articles

The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma.

Résumé : Mantle Cell Lymphoma (MCL) is often associated with progression, temporary response to therapy and a high relapse rate over time resulting in a poor long-term prognosis. Because MCL is classified as an incurable disease, therapeutic resistance is of great interest. However, knowledge about the biological mechanisms underlying resistance associated with MCL therapies and about associated predictors remains poor. The REFRACT-LYMA Cohort, a multicenter prospective cohort of patients with MCL, is set up to address this limitation. We here describe the study background, design and methods used for this cohort.
Abstract : Background: Mantle Cell Lymphoma (MCL) is often associated with progression, temporary response to therapy and a high relapse rate over time resulting in a poor long-term prognosis. Because MCL is classified as an incurable disease, therapeutic resistance is of great interest. However, knowledge about the biological mechanisms underlying resistance associated with MCL therapies and about associated predictors remains poor. The REFRACT-LYMA Cohort, a multicenter prospective cohort of patients with MCL, is set up to address this limitation. We here describe the study background, design and methods used for this cohort. Methods/Design: The REFRACT-LYMA Cohort Study aims at including all patients (>18 years old) who are diagnosed with MCL in any stage of the disease and treated in specialized oncology centers in three public hospitals in Northwestern France. Any such patient providing a signed informed consent is included. All subjects are followed up indefinitely, until refusal to participate in the study, emigration or death. The REFRACT-LYMA follow-up is continuous and collects data on socioeconomic status, medical status, MCL therapies and associated events (resistance, side effects). Participants also complete standardized quality of life (QOL) questionnaires. In addition, participants are asked to donate blood samples that will support ex vivo analysis of expression and functional assays required to uncover predictive biomarkers and companion diagnostics. If diagnostic biopsies are performed during the course of the disease, extracted biological samples are kept in a dedicated biobank.
Document type :
Journal articles
Complete list of metadata

Cited literature [32 references]  Display  Hide  Download

https://hal.archives-ouvertes.fr/hal-01524145
Contributor : Amel BOUAKAZ Connect in order to contact the contributor
Submitted on : Friday, March 9, 2018 - 1:41:26 PM
Last modification on : Friday, August 5, 2022 - 3:40:15 AM

File

s12885-016-2844-6.pdf
Publication funded by an institution

Identifiers

Citation

Matthieu Hanf, David Chiron, Sophie de Visme, Cyrille Touzeau, Hervé Maisonneuve, et al.. The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma.. BMC Cancer, 2016, 16 (1), pp.802. ⟨10.1186/s12885-016-2844-6⟩. ⟨hal-01524145⟩

Share

Metrics

Record views

127

Files downloads

79